CANDEX
DEAD

Serial Number

87117660

Owner

Senzer Limited

Filing Date

Jul 27, 2016

Add to watchlist:

No watchlists yet
View on USPTO

CANDEX Trademark

Serial Number: 87117660 • Registration: 5314743

CANDEX is a trademark filed by Senzer Limited on July 27, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

Senzer Limited (6 trademarks)

2 Angel Square

Entity Type: 99

Trademark Details

Filing Date

July 27, 2016

Registration Date

October 24, 2017

Published for Opposition

August 8, 2017

Cancellation Date

May 10, 2024

Goods & Services

Medical apparatus and instruments for the treatment of pain, nausea and vomiting, spasticity, anorexia, mental illness, drug addiction or dependence, neoplastic conditions and neurological conditions excluding those for the treatment of dizziness, headache or back pain; Medical apparatus and instruments in the nature of inhalers for the treatment of pain, nausea and vomiting, spasticity, anorexia, mental illness, drug addiction or dependence, neoplastic conditions and neurological conditions excluding those for the treatment of dizziness, headache or back pain; Medical apparatus and instruments in the nature of drug delivery systems for the treatment of pain, nausea and vomiting, spasticity, anorexia, mental illness, drug addiction or dependence, neoplastic conditions and neurological conditions excluding those for the treatment of dizziness, headache or back pain; Medical apparatus and instruments in the nature of microneedle arrays for delivering medications for the treatment of pain, nausea and vomiting, spasticity, anorexia, mental illness, drug addiction or dependence, neoplastic conditions and neurological conditions excluding those for the treatment of dizziness, headache or back pain

Medical preparations in the nature of pharmaceuticals for the treatment of pain, nausea and vomiting, spasticity, anorexia, mental illness, drug addiction or dependence, neoplastic conditions and neurological conditions excluding those for the treatment of dizziness, headache or back pain; Medical preparations in the nature of pharmaceutical preparations for injection for the treatment of pain, nausea and vomiting, spasticity, anorexia, mental illness, drug addiction or dependence, neoplastic conditions and neurological conditions excluding those for the treatment of dizziness, headache or back pain; Medical preparations in the nature of medicated transdermal drug delivery patches for use in the treatment of pain, nausea and vomiting, spasticity, anorexia, mental illness, drug addiction or dependence, neoplastic conditions and neurological conditions excluding those for the treatment of dizziness, headache or back pain; Medical preparations in the nature of drug delivery agents in the form of liquid medications, tablets, powders, capsules, inhalers, nasal sprays, orally disintegrating tablets, mouthwashes, that facilitate the delivery of pharmaceutical preparations for the treatment of pain, nausea and vomiting, spasticity, anorexia, mental illness, drug addiction or dependence, neoplastic conditions and neurological conditions excluding those for the treatment of dizziness, headache or back pain

Filing History

CANCELLED SEC. 8 (6-YR)
May 10, 2024 C8..
WITHDRAWAL OF ATTORNEY GRANTED
Sep 14, 2023 WOAG
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Sep 14, 2023 WOAR
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Oct 24, 2022 REM1
REGISTERED-PRINCIPAL REGISTER
Oct 24, 2017 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 8, 2017 NPUB
PUBLISHED FOR OPPOSITION
Aug 8, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 19, 2017 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 6, 2017 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 19, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 17, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 14, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 14, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 7, 2017 GNRN
NON-FINAL ACTION E-MAILED
Jun 7, 2017 GNRT
NON-FINAL ACTION WRITTEN
Jun 7, 2017 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
May 17, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 17, 2017 CRFA
ASSIGNED TO LIE
May 16, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 25, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 8, 2016 GNRN
NON-FINAL ACTION E-MAILED
Nov 8, 2016 GNRT
NON-FINAL ACTION WRITTEN
Nov 8, 2016 CNRT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 8, 2016 GNRN
NON-FINAL ACTION E-MAILED
Nov 8, 2016 GNRT
NON-FINAL ACTION WRITTEN
Nov 8, 2016 CNRT
ASSIGNED TO EXAMINER
Nov 8, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 1, 2016 NWOS
NEW APPLICATION ENTERED
Jul 30, 2016 NWAP